Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in the News.
Press releases published on April 2, 2025

Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient
Continued Clear Visual Evidence of Almost Completely Healed Skin After 6 weeks Treatment High Durability of Treatment Effect of QRX003 with Continuous Daily Dosing Patient Continues Not to Require Previously Necessary Medications With Patient’s Pruritus …

ProMOS Adopts Silvaco Victory TCAD Solution for the Development of Next-Gen Silicon Photonics Devices
SANTA CLARA, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO) (“Silvaco” or the “Company”), a provider of TCAD, EDA software and SIP solutions that enable semiconductor design and digital twin modeling through AI software and …

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BIIB080, an investigational antisense oligonucleotide (ASO) therapy …

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference
EMERYVILLE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA”; NASDAQ: XOMA), the biotech royalty aggregator, announced today Chief Investment Officer, Brad Sitko, will be a featured presenter at the Jones Healthcare and …

Aurora Spine Announces Publication of Biomechanical Study Demonstrating Superiority of SiLO TFX™ Sacroiliac Fusion System
CARLSBAD, California, April 02, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced …

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, …

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief Executive Officer …

American Tungsten Corp. Joins The Critical Mineral Institute
Vancouver, BC, April 02, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce that it has become a member of the Critical Minerals Institute (the “CMI”). The CMI …

Grove AI Welcomes Former Novartis, UCB, and Google Executives to Company Advisory Board
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- Grove AI, pioneer in life science automation using agentic AI, today announced the formation of its inaugural Advisory Board. Comprised of prominent leaders from pharmaceutical and technology sectors, the …

Bathroom Vanities Market Size to Reach US$ 52.90 Billion by 2031: In-Depth Research Report by The Insight Partners
US …

Vital Signs Monitoring Devices Market Set to Reach USD 66.82 Billion by 2030, Growing at a CAGR of 12.7% - Exclusive Report by The Insight Partners
US …

Moringa: Learn Why These Moringa Powder Supplements Are Transforming Energy, Immunity, and Overall Health
LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) -- Moringa Oleifera, often called the “Miracle Tree,” is rapidly gaining recognition in the U.S. as a superfood for its remarkable health benefits. From boosting daily energy levels to fortifying immune support, …

Defiance Launches $GLDY, Gold Enhanced Options Income ETF
MIAMI, April 02, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs is proud to announce the launch of GLDY, the Defiance Gold Enhanced Options Income ETF. GLDY offers investors a new opportunity to seek current income while gaining indirect exposure to the price …

Marex Group plc provides preliminary Q1 results range and hosts Investor Day in New York
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (Nasdaq: MRX) (‘Marex’), the diversified global financial services platform, provides a Q1 trading update at its Investor Day, being held today at the Nasdaq Marketsite in New York City. Marex …

Lack of Employment Services Exacerbates Economic Disparities for English Speakers in Montréal
Montreal, April 02, 2025 (GLOBE NEWSWIRE) -- A new report by the Provincial Employment Roundtable (PERT) reveals significant employment and income disparities for English speakers in Montréal, highlighting the urgent need for targeted employment services …

Syntiant to Unveil Vision Transformer Security Solution at ISC West 2025
IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Syntiant Corp., the recognized leader in low-power edge AI deployment, today announced it will demonstrate its multimodal vision transformer (ViT) at ISC West 2025 in Las Vegas, April 2-4. Deployed on an …

Prospect’s Real Estate Private Credit Platform Provides $10.9 Million to Class A Stabilized Cash Flowing Multifamily Property in Brooklyn
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Management L.P. (“Prospect”), through its real estate private credit platform, has closed on an investment to recapitalize The Frederick, a 193-unit, Class A stabilized cash flowing multifamily …

Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment
Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment First subjects dosed in double-blind, placebo-controlled trial assessing AT-7687’s safety, tolerability, …

Employee Trust Fuels Financial Success at the 100 Best Companies to Work For in 2025
Oakland, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Can employee trust be measured in dollars and cents? The 2025 Fortune 100 Best Companies to Work For® have proven that the answer is a resounding yes. On average, the 100 Best Companies earn 8.5 times …

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of …